A citation-based method for searching scientific literature

Christoph Kornauth, Tea Pemovska, Gregory I Vladimer, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Martin Erl, Harald Esterbauer, Ruth Exner, Verena Felsleitner-Hauer, Maurizio Forte, Alexander Gaiger, Klaus Geissler, Hildegard T Greinix, Wolfgang Gstöttner, Marcus Hacker, Bernd Lorenz Hartmann, Alexander W Hauswirth, Tim Heinemann, Daniel Heintel, Mir Alireza Hoda, Georg Hopfinger, Ulrich Jaeger, Lukas Kazianka, Lukas Kenner, Barbara Kiesewetter, Nikolaus Krall, Gerhard Krajnik, Stefan Kubicek, Trang Le, Simone Lubowitzki, Marius E Mayerhoefer, Elisabeth Menschel, Olaf Merkel, Katsuhiro Miura, Leonhard Müllauer, Peter Neumeister, Thomas Noesslinger, Katharina Ocko, Leopold Öhler, Michael Panny, Alexander Pichler, Edit Porpaczy, Gerald W Prager, Markus Raderer, Robin Ristl, Reinhard Ruckser, Julius Salamon, Ana-Iris Schiefer, Ann-Sofie Schmolke, Ilse Schwarzinger, Edgar Selzer, Christian Sillaber, Cathrin Skrabs, Wolfgang R Sperr, Ismet Srndic, Renate Thalhammer, Peter Valent, Emiel van der Kouwe, Katrina Vanura, Stefan Vogt, Cora Waldstein, Dominik Wolf, Christoph C Zielinski, Niklas Zojer, Ingrid Simonitsch-Klupp, Giulio Superti-Furga, Berend Snijder, Philipp B Staber. Cancer Discov 2022
Times Cited: 14







List of co-cited articles
81 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.
Berend Snijder, Gregory I Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin,[...]. Lancet Haematol 2017
76
50

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Disha Malani, Ashwini Kumar, Oscar Brück, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmäki, Olli Dufva, Matti Kankainen, Samuli Eldfors,[...]. Cancer Discov 2022
15
42

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.
Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Evgeny Kulesskiy, Mika Kontro, Riikka Karjalainen, Muntasir Mamun Majumder, Disha Malani, Astrid Murumägi, Jonathan Knowles,[...]. Sci Rep 2014
171
35


Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.
Georgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, Yann Jamin, Javier Fernández-Mateos, Khurum Khan, Andrea Lampis, Katherine Eason, Ian Huntingford, Rosemary Burke,[...]. Science 2018
771
35



An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL.
Sigrid S Skånland, Andrea Cremaschi, Henrik Bendiksen, Johanne U Hermansen, Deepak B Thimiri Govinda Raj, Ludvig A Munthe, Geir E Tjønnfjord, Kjetil Taskén. Leukemia 2020
15
28

High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors.
Patrick D Bhola, Eman Ahmed, Jennifer L Guerriero, Ewa Sicinska, Emily Su, Elizaveta Lavrova, Jing Ni, Otari Chipashvili, Timothy Hagan, Marissa S Pioso,[...]. Sci Signal 2020
26
28

A critical appraisal of the "human tumor stem-cell assay".
P Selby, R N Buick, I Tannock. N Engl J Med 1983
394
28

American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays.
Harold J Burstein, Pamela B Mangu, Mark R Somerfield, Deborah Schrag, David Samson, Lawrence Holt, Debra Zelman, Jaffer A Ajani. J Clin Oncol 2011
98
28

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Norman Sachs, Joep de Ligt, Oded Kopper, Ewa Gogola, Gergana Bounova, Fleur Weeber, Anjali Vanita Balgobind, Karin Wind, Ana Gracanin, Harry Begthel,[...]. Cell 2018
725
28


Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy.
Joan Montero, Kristopher A Sarosiek, Joseph D DeAngelo, Ophélia Maertens, Jeremy Ryan, Dalia Ercan, Huiying Piao, Neil S Horowitz, Ross S Berkowitz, Ursula Matulonis,[...]. Cell 2015
238
21

Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
Vignesh Narasimhan, Josephine A Wright, Michael Churchill, Tongtong Wang, Rachele Rosati, Tamsin R M Lannagan, Laura Vrbanac, Anne B Richardson, Hiroki Kobayashi, Timothy Price,[...]. Clin Cancer Res 2020
61
21

Patient-derived organoid (PDO) platforms to facilitate clinical decision making.
Lisa Liu, Lei Yu, Zhichao Li, Wujiao Li, WeiRen Huang. J Transl Med 2021
24
21

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors.
Oliver Jonas, Heather M Landry, Jason E Fuller, John T Santini, Jose Baselga, Robert I Tepper, Michael J Cima, Robert Langer. Sci Transl Med 2015
106
21

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
Hervé Tiriac, Pascal Belleau, Dannielle D Engle, Dennis Plenker, Astrid Deschênes, Tim D D Somerville, Fieke E M Froeling, Richard A Burkhart, Robert E Denroche, Gun-Ho Jang,[...]. Cancer Discov 2018
434
21

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.
Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan, Padhma Radhakrishnan, Harikrishna Narasimhan, Muthu Dhandapani, Nilesh Brijwani, Dency D Pinto, Arun Prasath, Basavaraja U Shanthappa,[...]. Nat Commun 2015
181
21

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, Céline Gavoille, Coraline Dubot, Nicolas Isambert, Mario Campone, Olivier Trédan, Marie-Ange Massiani, Cécile Mauborgne,[...]. Lancet Oncol 2015
650
21

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models.
Max A Stockslager, Seth Malinowski, Mehdi Touat, Jennifer C Yoon, Jack Geduldig, Mahnoor Mirza, Annette S Kim, Patrick Y Wen, Kin-Hoe Chow, Keith L Ligon,[...]. Cell Rep 2021
8
37

Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.
Cristina E Tognon, Rosalie C Sears, Gordon B Mills, Joe W Gray, Jeffrey W Tyner. Annu Rev Cancer Biol 2021
4
75

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
Tea Pemovska, Mika Kontro, Bhagwan Yadav, Henrik Edgren, Samuli Eldfors, Agnieszka Szwajda, Henrikki Almusa, Maxim M Bespalov, Pekka Ellonen, Erkki Elonen,[...]. Cancer Discov 2013
246
21

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Christian Schmidl, Gregory I Vladimer, André F Rendeiro, Susanne Schnabl, Thomas Krausgruber, Christina Taubert, Nikolaus Krall, Tea Pemovska, Mohammad Araghi, Berend Snijder,[...]. Nat Chem Biol 2019
21
21

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.
Ye Yao, Xiaoya Xu, Lifeng Yang, Ji Zhu, Juefeng Wan, Lijun Shen, Fan Xia, Guoxiang Fu, Yun Deng, Mengxue Pan,[...]. Cell Stem Cell 2020
223
21

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
Chantal Pauli, Benjamin D Hopkins, Davide Prandi, Reid Shaw, Tarcisio Fedrizzi, Andrea Sboner, Verena Sailer, Michael Augello, Loredana Puca, Rachele Rosati,[...]. Cancer Discov 2017
482
21

Cryopreservation of primary B cells minimally influences their signaling responses.
Johanne U Hermansen, Geir E Tjønnfjord, Ludvig A Munthe, Kjetil Taskén, Sigrid S Skånland. Sci Rep 2018
9
22

Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.
Ishwarya Murali, Siddha Kasar, Aishath Naeem, Svitlana Tyekucheva, Jasneet K Khalsa, Emily M Thrash, Gilad Itchaki, Dimitri Livitz, Ignaty Leshchiner, Shuai Dong,[...]. Blood 2021
19
14

Prediction of drug combination effects with a minimal set of experiments.
Aleksandr Ianevski, Anil K Giri, Prson Gautam, Alexander Kononov, Swapnil Potdar, Jani Saarela, Krister Wennerberg, Tero Aittokallio. Nat Mach Intell 2019
43
14

B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia.
Sigrid S Skånland, Linda Karlsen, Kjetil Taskén. Scand J Immunol 2020
5
40

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia.
Ida K Myhrvold, Andrea Cremaschi, Johanne U Hermansen, Geir E Tjønnfjord, Ludvig A Munthe, Kjetil Taskén, Sigrid S Skånland. Oncotarget 2018
13
15

Human Organ Chip Models Recapitulate Orthotopic Lung Cancer Growth, Therapeutic Responses, and Tumor Dormancy In Vitro.
Bryan A Hassell, Girija Goyal, Esak Lee, Alexandra Sontheimer-Phelps, Oren Levy, Christopher S Chen, Donald E Ingber. Cell Rep 2017
181
14

Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
David A Wheeler, Naoko Takebe, Toshinori Hinoue, Katherine A Hoadley, Maria F Cardenas, Alina M Hamilton, Peter W Laird, Linghua Wang, Adrienne Johnson, Ninad Dewal,[...]. Cancer Cell 2021
30
14

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.
Yoko S DeRose, Guoying Wang, Yi-Chun Lin, Philip S Bernard, Saundra S Buys, Mark T W Ebbert, Rachel Factor, Cindy Matsen, Brett A Milash, Edward Nelson,[...]. Nat Med 2011
649
14

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, Maria Schwaederle, Michael E Hahn, Casey B Williams, Pradip De, Amy Krie, David E Piccioni, Vincent A Miller,[...]. Nat Med 2019
267
14

A pan-cancer organoid platform for precision medicine.
Brian M Larsen, Madhavi Kannan, Lee F Langer, Benjamin D Leibowitz, Aicha Bentaieb, Andrea Cancino, Igor Dolgalev, Bridgette E Drummond, Jonathan R Dry, Chi-Sing Ho,[...]. Cell Rep 2021
18
14

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.
Richard A Klinghoffer, S Bahram Bahrami, Beryl A Hatton, Jason P Frazier, Alicia Moreno-Gonzalez, Andrew D Strand, William S Kerwin, Joseph R Casalini, Derek J Thirstrup, Sheng You,[...]. Sci Transl Med 2015
56
14

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.
Anja Irmisch, Ximena Bonilla, Stéphane Chevrier, Kjong-Van Lehmann, Franziska Singer, Nora C Toussaint, Cinzia Esposito, Julien Mena, Emanuela S Milani, Ruben Casanova,[...]. Cancer Cell 2021
27
14


Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Keith T Flaherty, Robert J Gray, Alice P Chen, Shuli Li, Lisa M McShane, David Patton, Stanley R Hamilton, P Mickey Williams, A John Iafrate, Jeffrey Sklar,[...]. J Clin Oncol 2020
78
14


Cancer modeling meets human organoid technology.
David Tuveson, Hans Clevers. Science 2019
324
14

American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays.
Deborah Schrag, Harinder S Garewal, Harold J Burstein, David J Samson, Daniel D Von Hoff, Mark R Somerfield. J Clin Oncol 2004
165
14

Precision medicine for cancer with next-generation functional diagnostics.
Adam A Friedman, Anthony Letai, David E Fisher, Keith T Flaherty. Nat Rev Cancer 2015
325
14


Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
Michael P Menden, Dennis Wang, Mike J Mason, Bence Szalai, Krishna C Bulusu, Yuanfang Guan, Thomas Yu, Jaewoo Kang, Minji Jeon, Russ Wolfinger,[...]. Nat Commun 2019
125
14

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Hui Gao, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Mallika Singh, Chao Zhang, Christian Schnell, Guizhi Yang, Yun Zhang,[...]. Nat Med 2015
716
14

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Alejandra Bruna, Oscar M Rueda, Wendy Greenwood, Ankita Sati Batra, Maurizio Callari, Rajbir Nath Batra, Katherine Pogrebniak, Jose Sandoval, John W Cassidy, Ana Tufegdzic-Vidakovic,[...]. Cell 2016
263
14

Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells.
Brent M Kuenzi, Jisoo Park, Samson H Fong, Kyle S Sanchez, John Lee, Jason F Kreisberg, Jianzhu Ma, Trey Ideker. Cancer Cell 2020
62
14

Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.
Marc Hafner, Mario Niepel, Mirra Chung, Peter K Sorger. Nat Methods 2016
269
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.